Ashvin Medicara Archives - Ashvinmedicara

How Global Pharmacy Practices Compare to the U.S. System

Brian RogersJune 6, 20240186 views

This article compares the accessibility of antibiotics, erectile dysfunction medications, and acne treatments across various countries, highlighting the differences between prescription requirements and over-the-counter (OTC) availability. While the U.S. enforces strict prescription regulations, leading to higher costs and lower customer satisfaction, many other countries offer broader OTC access, resulting in greater satisfaction and lower costs. The analysis underscores the need for the U.S. to adopt a balanced approach that maintains safety while improving access to medications.

Personal Medication Importation: Navigating CBP Regulations

Brian RogersJune 5, 20240566 views

The U.S. Customs and Border Protection Agency generally prohibits the importation of more than a 90-day supply of medication. This policy aims to balance the need for drug safety with recognizing that many Americans turn to international sources for their prescription medications due to high domestic prices or availability issues. Despite strict regulations, the FDA inspects less than 1% of all packages presumed to contain drugs, significantly reducing the likelihood of small personal shipments being intercepted. This article explores the complexities and implications of current import regulations and highlights the efforts of organizations like Ashvin Medicara to advocate for better access to affordable medications.

Brian Rogers – Director of Ashvin Medicara

GeneralJune 4, 20240272 views

Brian Rogers, Director of Ashvin Medicara, exemplifies resilience and dedication to healthcare advocacy. With over 30 years of sobriety, Brian’s journey from addiction to advocating for accessible, affordable medications highlights his profound understanding of global healthcare challenges and a relentless pursuit of compassionate healthcare reform

Beyond the Patents: The Monopoly Practices of Big Pharma and What American Consumers Aren’t Told

Brian RogersJune 3, 20240207 views

The high cost of prescription drugs in the U.S. is driven by Big Pharma’s patent practices and strategic blocking of affordable generic medications, especially from India. This article reveals how evergreening tactics, intense lobbying, and restrictive FDA regulations keep drug prices artificially high and prevent the entry of cheaper alternatives. These monopoly practices significantly impact consumers, leading to high healthcare costs and limited access to essential medications. Organizations like Ashvin Medicara play a crucial role in advocating for the importation of safe and affordable generics, challenging the power of Big Pharma and supporting policy changes for better healthcare access.

The Silent Conspiracy: How Regulators and Corporations Control Your Health

Brian RogersJune 3, 20240159 views

The regulatory landscape involving entities like the FDA, LegitScript, Meta, and Google is often seen as a guardian of public health. However, a closer look reveals that, much like underground steroid forums, these organizations control information and access to healthcare products for financial gain. This article explores the parallels between these mainstream and underground entities, highlighting how they prioritize profits over genuine healthcare needs. The discussion covers the manipulation of health information, censorship, and the economic interests driving these practices. It also advocates for regulatory reforms and supports organizations like Ashvin Medicara, which promote transparency and access to affordable medications.

Affordable Healthcare: Legalities of Importing Medications from Abroad

Brian RogersJune 3, 20240131 views

The skyrocketing cost of prescription medications in the United States has driven many consumers to seek more affordable alternatives through online pharmacies, especially those based overseas. While the prospect of obtaining a 90-day supply of medication at a fraction of domestic costs is enticing, it is crucial to understand the legal landscape and potential risks involved. The FDA generally restricts the importation of prescription drugs for personal use, but specific conditions allow the importation of a 90-day supply of unapproved drugs. Organizations like Ashvin Medicara help verify and ensure that online pharmacies meet international safety standards, providing consumers with peace of mind when ordering medications. Despite legal and regulatory hurdles, informed consumers can navigate these complexities to access affordable medications safely.

The Dark Side of IndiaMART: Compromising Global Healthcare and Safety

Brian RogersMay 31, 20240284 views

IndiaMART, a major online marketplace, is under scrutiny for its role in the sale of pharmaceuticals. The platform’s lack of stringent verification processes and focus on bulk sales have led to the distribution of tainted medications, raising significant global health concerns. Incidents involving suppliers like QP Pharmachem highlight the dangers of unregulated pharmaceutical sales, including the risk of contamination with harmful substances. This article delves into the implications for global healthcare, the erosion of trust in legitimate Indian pharmacies, and the influence of regulatory bodies like LegitScript, emphasizing the need for stricter oversight and consumer awareness.

Healthcare Tyranny: The Stranglehold of Big Pharma and Government Overreach

Brian RogersMay 30, 20240179 views

In the U.S., an alarming alliance between big pharma, congressional elites, and government agencies is transforming healthcare into a system of control and oppression. Through extensive lobbying and financial contributions, big pharma has captured the legislative process, ensuring healthcare policies prioritize profit margins over patient well-being. Government agencies like the FDA enforce monopolistic practices, restricting access to affordable medications. This article explores the dire consequences of this collusion and calls for reclaiming healthcare freedom by breaking monopolies and expanding access to affordable medications from trusted international sources.

The Dark Side of Online Pharmacies: Exploitative Marketing and the Risks of Misinformation

Brian RogersMay 29, 20240141 views

Consumers misled by false claims may purchase ineffective or harmful products, leading to serious health complications and financial loss. Exploitative marketing tactics can erode trust in online pharmaceutical services, deterring individuals from engaging with legitimate providers. To protect yourself, verify the authenticity of online pharmacies, seek out verified reviews, consult healthcare professionals, and beware of unusual marketing tactics. Look for the Ashvin Medicara Stamp of approval to ensure safety. Remaining vigilant and informed helps consumers avoid the pitfalls of unregulated online pharmacies and make safer health choices.

Is the FDA Complicit in the Healthcare Crisis?

Brian RogersMay 29, 20240138 views

The FDA’s restrictive policies on the importation of affordable generic medications from countries like India raise significant concerns about their impact on healthcare costs and access. Critics argue these regulations favor Big Pharma’s interests, leading to higher drug prices and compromised consumer health. Ashvin Medicara advocates for policy reevaluation to ensure essential medications are accessible without compromising safety.